Characterization of this “de-novo” EMT-phenotype in SKBR-3 revealed decreased HER-2 levels and expression of a heavily N-glycosylated variant of β1-integrin, associated malignant traits in BC cells [27]. Here, ERBB2 is linked to breast cancer.